Caris Life Sciences, Inc. (CAI)
Data as of , from SEC Form 4 filings.
See up to 3 months of CAI. The 7-day demo opens the 1M and 3M ranges and puts CAI on your watchlist.
Start 7-day demoLatest CAI insider trades
About Caris Life Sciences, Inc. (CAI)
Caris Life Sciences, Inc. is an SEC registrant, filing under CIK 0002019410, classified as medical laboratories. We track it alongside the rest of the Health Care sector.
CAI Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 5 | 1,004,712 | $27.20M |
| Grant or award | 8 | 105,536 | |
| Option exercise | 6 | 3,300,000 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
CAI insider transactions (Form 4)
2541 Form 4 filings on record, the earliest from Jun 20, 2025, newest first. Filing history page 2 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peter M. Castleman - Director | Grant or award | Common Stock | 5,509 | $20.06 | $111K | |
| David Baxley Spetzler - Officer | Open-market purchase | Common Stock | 400 | $23.85 | $10K | |
| John Russel Denton - Officer | Open-market purchase | Common Stock | 4,184 | $24.09 footnote F1 | $101K | |
| ||||||
 T. Danny Phillips - Director | Option exercise | Common Stock | 100,000 | $2.44 | $244K | |
| T. Danny Phillips - Director | Option exercise | Stock Option | 100,000 | $0.00 | - | |
| David Baxley Spetzler - Officer | Tax withholding / forfeiture | Common Stock | 63,509 | $29.75 | $1.89M | |
| George Poste - Director | Option exercise | Common Stock | 125,000 | $2.44 | $305K | |
| George Poste - Director | Tax withholding / forfeiture | Common Stock | 48,022 | $29.75 | $1.43M | |
| George Poste - Director | Tax withholding / forfeiture | Common Stock | 91,495 | $29.75 | $2.72M | |
| George Poste - Director | Option exercise | Stock Option | 125,000 | $0.00 | - | |
| David D. Halbert - Officer | Tax withholding / forfeiture | Common Stock | 141,956 | $29.75 | $4.22M | |
| Peter M. Castleman - Director | Grant or award | Common Stock | 16,129 | $0.00 | - | |
| Peter M. Castleman - Director | Other | Common Stock | 10,245,906 | $0.00 | - | |
| Peter M. Castleman - Director | Grant or award | Stock Option | 2,500 | $0.00 | - | |
| Peter M. Castleman - Director | Other | Series A Preferred Stock | 40,983,607 | - | - | |
| Jon Halbert - Director | Grant or award | Common Stock | 16,129 | $0.00 | - | |
| Jon Halbert - Director | Other | Common Stock | 1,250,000 | $0.00 | - | |
| Jon Halbert - Director | Other | Series A Preferred Stock | 5,000,000 | - | - | |
| David D. Halbert - Officer | Grant or award | Common Stock | 360,750 | $0.00 | - | |
| David D. Halbert - Officer | Grant or award | Common Stock | 413,839 | $0.00 | - | |
| David D. Halbert - Officer | Other | Common Stock | 104,761,535 | $0.00 | - | |
| David D. Halbert - Officer | Other | Series A Preferred Stock | 389,416,484 | - | - | |
| David D. Halbert - Officer | Other | Series B Preferred Stock | 29,629,630 | - | - | |
| H. Whitney Vi L. P. J. - 10% Owner | Other | Common Stock | 12,516,834 | - | - | |
| H. Whitney Vi L. P. J. - 10% Owner | Other | Series A Preferred Stock | 50,067,334 | $0.00 | - | |
Recent CAI Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JOHN RUSSEL DENTON | Officer | 7,500 | $239K | View on EDGAR | |
| BRIAN J BRILLE | Officer, Director | 400,000 |
CAI insider trading FAQ
What is the latest insider trade for CAI?
Caris Life Sciences, Inc. (CAI) had 11 insider filings in the last 90 days, with the most recent on 2026-09-23. The full record for CAI runs to 41 Form 4 filings, the earliest from 2025-06-20. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying CAI stock?
No insider purchases of CAI were filed in the last 90 days. 4 purchases are on record for this company.
How many insiders are selling CAI stock?
5 insider sales of CAI were filed in the last 90 days, totaling $27.20M.
Where can I see CAI SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects CAI Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - John Russel Denton view on EDGAR
- - Brian J. Brille view on EDGAR
- - David Baxley Spetzler view on EDGAR
- - Peter M. Castleman view on EDGAR
- - T. Danny Phillips view on EDGAR
- - Lloyd Minor view on EDGAR
- - Joseph E. Gilliam view on EDGAR
- - David Paul Fredrickson view on EDGAR
- - Jeff L. Vacirca view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where CAI's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow CAI with a 7-day demo
- CAI on your watchlist
- Every CAI Form 4 filing on record
- Up to 3 months of CAI price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
